Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -10,819 | -15,016 | -7,828 | N/A |
| Depreciation Amortization | 18 | 72 | 124 | N/A |
| Other Working Capital | -329 | 1,394 | -1,839 | N/A |
| Other Operating Activity | 1,558 | 646 | 2,147 | 0 |
| Operating Cash Flow | $-9,572 | $-12,904 | $-7,396 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -18 | 43 | N/A | N/A |
| Other Investing Activity | 0 | 40 | 0 | 0 |
| Investing Cash Flow | $-18 | $83 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 10,000 | N/A | 3,250 | N/A |
| Common Stock Issued | 57,815 | 0 | 15 | N/A |
| Other Financing Activity | 13,358 | 6,085 | 9,402 | 0 |
| Financing Cash Flow | $81,174 | $6,085 | $12,667 | $N/A |
| Beginning Cash Position | 4,364 | 11,100 | 5,829 | N/A |
| End Cash Position | 75,948 | 4,364 | 11,100 | N/A |
| Net Cash Flow | $71,584 | $-6,736 | $5,271 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,572 | -12,904 | -7,396 | N/A |
| Capital Expenditure | -18 | -21 | N/A | N/A |
| Free Cash Flow | -9,590 | -12,925 | -7,396 | 0 |